The high-expression group of PCDH17 demonstrated significantly elevated scores in immune-related processes, including cancer antigen presentation, T cell recruitment, CD8-positive T cell recruitment, and Treg cell recruitment, compared to the low-expression group. Here, CD8A is linked to cancer.